In vitro, and in vivo, evaluation of dihydropyrimidinone C-5 amides as potent and selective α(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

James C. Barrow, Philippe G. Nantermet, Harold G. Selnick, Kristen L. Glass, Kenneth E. Rittle, Kevin F. Gilbert, Thomas G. Steele, Carl F. Homnick, Roger M. Freidinger, Rick W. Ransom, Paul Kling, Duane Reiss, Theodore P. Broten, Terry W. Schorn, Raymond S.L. Chang, Stacey S. O'Malley, Timothy V. Olah, Joan D. Ellis, Andrea Barrish, Kelem KassahunPaula Leppert, Dhanapalan Nagarathnam, Carlos Forray

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'In vitro, and in vivo, evaluation of dihydropyrimidinone C-5 amides as potent and selective α(1A) receptor antagonists for the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences